Embecta EMBC
NASDAQ EMBC
$5.23 -0.24 (-4.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Embecta (EMBC) Cash from Financing Activities (2020 - 2026)

Embecta (EMBC) posted Cash from Financing Activities of -$41.5 million for Q1 2026, up 19.57% sequentially from -$51.6 million in Q4 2025, and down 11.26% YoY from -$46.8 million in Q1 2025.

Embecta (EMBC) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Embecta has reported Cash from Financing Activities for 7 years, with the latest figure at -$41.5 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 11.26% year-over-year to -$41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$237.3 million (down 81.7% YoY) and the FY2025 annual result came in at -$226.7 million, down 208.86% from the prior year.
  • Cash from Financing Activities grew to -$41.5 million in Q1 2026 per EMBC's latest filing, from -$51.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $90.3 million in Q1 2022 and troughed at -$81.6 million in Q3 2025.
  • A 5-year average of -$20.9 million and a median of -$13.5 million in 2023 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities surged 179.63% in 2022, then plunged 469.7% in 2023.
  • Over 5 years, Cash from Financing Activities stood at -$6.1 million in 2022, then plunged by 121.31% to -$13.5 million in 2023, then slumped by 234.81% to -$45.2 million in 2024, then fell by 14.16% to -$51.6 million in 2025, then increased by 19.57% to -$41.5 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$41.5 million, -$51.6 million, and -$81.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Embecta 305.26 Mn 87.06 Mn 153.30 Mn 112.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 112.40 Mn
Jun 30, 2026 112.40 Mn
Mar 31, 2026 -41.50 Mn
Mar 31, 2026 -41.50 Mn
Dec 31, 2025 -51.60 Mn
Dec 31, 2025 -51.60 Mn
Sep 30, 2025 -81.60 Mn
Sep 30, 2025 -81.60 Mn
Jun 30, 2025 -62.60 Mn
Jun 30, 2025 -62.60 Mn
Mar 31, 2025 -37.30 Mn
Mar 31, 2025 -37.30 Mn
Dec 31, 2024 -45.20 Mn
Dec 31, 2024 -45.20 Mn
Sep 30, 2024 -36.60 Mn
Sep 30, 2024 -36.60 Mn
Jun 30, 2024 -11.50 Mn
Jun 30, 2024 -11.50 Mn
Mar 31, 2024 -11.80 Mn
Mar 31, 2024 -11.80 Mn